Analysis of genome and blood components for elucidation and treatment on dementia

Trial Profile

Analysis of genome and blood components for elucidation and treatment on dementia

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Aug 2013

At a glance

  • Drugs Fluvoxamine (Primary) ; Risperidone (Primary) ; TJ 54 (Primary)
  • Indications Dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Aug 2013 Status changed from recruiting to completed, based on publication of results.
    • 14 Aug 2013 Results published in the Journal of Clinical Psychopharmacology.
    • 13 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top